Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Feb;86(2):163-7.
doi: 10.1136/bjo.86.2.163.

Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study

Gerasimos Anastassiou  1 , Arnd Heiligenhaus, Nikos Bechrakis, Elisabeth Bader, Norbert Bornfeld, Klaus-Peter Steuhl
Affiliations

Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study

Gerasimos Anastassiou et al. Br J Ophthalmol. 2002 Feb.

Abstract

Aim: To determine prognostic factors for recurrence of disease and tumour related mortality in patients with conjunctival melanoma.

Methods: A retrospective analysis of clinical and histopathological data of 69 patients with histologically verified conjunctival melanoma.

Results: As univariate analysis showed, significant risk factors for the development of recurrence were: irregular pigmentation (RR = 2.0, p = 0.0007), incomplete surgical excision (RR = 3.5, p = 0.008), tumour invasion deeper than in substantia propria (RR = 3.9, p = 0.008), and presence of epithelioid tumour cells (RR = 2.9, p = 0.05). For tumour related mortality a significantly increased risk was found for tumour location in palpebral conjunctiva, caruncle, plica, or fornices (RR = 5.9, p = 0.001), for tumour infiltration deeper than the substantia propria (RR = 5.5, p = 0.001), for incomplete surgical excision (RR = 4.4, p = 0.05), and for nodular or mixed (nodular and superficial) growth pattern of the tumours (RR = 1.2, p = 0.002). The use of an adjuvant therapy for the surgical excision of the melanomas had no statistically significant influence upon the development of recurrent disease nor upon the tumour related mortality.

Conclusion: These data present similar clinical and histopathological risk factors for patients with conjunctival melanoma as reported previously. The present study also addresses the failure of retrospective studies on conjunctival melanoma to prove the efficacy of a supplementary therapy to surgical excision.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier analysis for recurrence free survival. The log rank test for univariate analysis was assessed.
Figure 2
Figure 2
Kaplan-Meier analysis for overall tumour related survival. The log rank test for univariate analysis was assessed.
See this image and copyright information in PMC

Comment in

  • Conjunctival melanoma.
    Shields CL. Shields CL. Br J Ophthalmol. 2002 Feb;86(2):127. doi: 10.1136/bjo.86.2.127. Br J Ophthalmol. 2002. PMID: 11815331 Free PMC article. No abstract available.

References

    1. Lommatzsch PK, Lommatzsch RE, Kirsch I, et al. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol 1990;74:615–9. - PMC - PubMed
    1. Seregard S, Kock E. Conjunctival malignant melanoma in Sweden 1969–91. Acta Ophthalmol (Copenh) 1992;70:289–96. - PubMed
    1. Norregaard JC, Gerner N, Jensen OA, et al. Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol 1996;234:569–72. - PubMed
    1. Paridaens AD, Minassian DC, McCartney AC, et al. Prognostic factors in primary malignant melanoma of the conjunctiva:a clinicopathological study of 256 cases. Br J Ophthalmol 1994;78:252–9. - PMC - PubMed
    1. Finger PT, Czechonska G, Liarikos S. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br J Ophthalmol 1998;82:476–9. - PMC - PubMed

MeSH terms